Deferred income
Boston Scientific Deferred income decreased by 1.3% to $309.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.6%, from $290.00M to $309.00M. Over 4 years (FY 2020 to FY 2024), Deferred income shows an upward trend with a 22.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase generally signals strong future revenue growth and customer demand, while a decrease may indicate a slowdown in new business or rapid fulfillment of existing contracts.
Detailed definition
This represents payments received from customers for services or products that have not yet been delivered or earned. As...
Peer comparison
Common in subscription and service-based businesses; peers report this as deferred revenue or unearned premiums.
current_liabilities_deferred_revenue_currentHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $141.00M | $160.00M | $208.00M | $212.00M | $222.00M | $216.00M | $220.00M | $231.00M | $242.00M | $246.00M | $266.00M | $280.00M | $284.00M | $290.00M | $306.00M | $306.00M | $313.00M | $309.00M |
| QoQ Change | — | +13.5% | +30.0% | +1.9% | +4.7% | -2.7% | +1.9% | +5.0% | +4.8% | +1.7% | +8.1% | +5.3% | +1.4% | +2.1% | +5.5% | +0.0% | +2.3% | -1.3% |
| YoY Change | — | — | — | — | +57.4% | +35.0% | +5.8% | +9.0% | +9.0% | +13.9% | +20.9% | +21.2% | +17.4% | +17.9% | +15.0% | +9.3% | +10.2% | +6.6% |
Deferred income at Other Companies
Frequently Asked Questions
- What is Boston Scientific's deferred income?
- Boston Scientific (BSX) reported deferred income of $309.00M in Q3 2025.
- How has Boston Scientific's deferred income changed year-over-year?
- Boston Scientific's deferred income increased by 6.6% year-over-year, from $290.00M to $309.00M.
- What is the long-term trend for Boston Scientific's deferred income?
- Over 4 years (2020 to 2024), Boston Scientific's deferred income has grown at a 22.0% compound annual growth rate (CAGR), from $138.00M to $306.00M.
- What does deferred income mean?
- Money received in advance for services or products that the company has not yet provided.